Civilization Ventures Management, Llc
Venture capitalTiburon · Pre-Seed–Growth · 3 people tracked
Find your way into Civilization Ventures Management, Llc
Each arrow is one introduction. Sign up to fill in the first one.
Ask David Schaffer to introduce you to Samir Malhotra
You →David · together at Rewrite Therapeutics →Samir
Ask Jamie Chen to introduce you to Shahram Seyedin-Noor
You →Jamie · together at Rewrite Therapeutics →Shahram
Ask Sam Okafor to introduce you to Sonia Setayesh
You →Sam · together at Rewrite Therapeutics →Sonia
Sign up to find every way you can get introduced to Civilization Ventures Management, Llc
- Your email: who you already know at Civilization Ventures Management, Llc, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Civilization Ventures Management, Llc team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
Civilization Ventures invests in life sciences and health innovation, focusing on genomics and diagnostics, digital health, and synthetic biology (including gene and cell therapies). The firm leads pre-seed and seed rounds, backing founders early and continuing to support them as they scale through an Opportunity Fund. Its track record includes companies that have reached public listings and notable acquisitions across gene therapy, molecular diagnostics, telemedicine, and single-cell analysis.
Source: firm website, verified Sep 29, 2026.
Team · 3 people
from the firm's website & public directoriesFounder mafia
2 people who came through Civilization Ventures Management, Llc went on to found or lead other companies.
What they invest in
from 63 of 70 portfolio companiesBiotech ×42AI & Machine Learning ×26Healthtech ×26Digital Health ×20Medical Devices ×20Deep Tech ×13SaaS ×9Enterprise Software ×5
HQs:United States×43United Kingdom×3Australia×1Canada×1Italy×1
Who they back
founder profiles across 43 portfolio companiesFounding team size:solo founder×122 founders×153 founders×104+ founders×6
Where their founders studiedfrom 57 founders with education data
University of California, Berkeley ×6Harvard Medical School ×5Massachusetts Institute of Technology ×4Princeton University ×4Stanford University ×4Stanford University School of Medicine ×4Harvard University ×3Northeastern University ×3
What their founders studiedfrom 61 founders with field-of-study data
Life Sciences ×31Engineering ×18Computer Science ×11Medicine ×11Business & Management ×5Chemistry ×5Mathematics & Statistics ×5Economics ×4
Where their founders worked beforefrom 56 founders with career history
Stanford University ×6University of California, San Francisco ×610x Genomics ×510X Genomics ×4Google ×3Harvard Medical School ×3Massachusetts Institute of Technology ×3Affymetrix ×2
Accelerator rootsportfolio companies that came through a program
42 founders hold a PhD · 3 hold an MBA (of 61 with degree data)
Investments · 70 tracked
founders shown can be your intro pathBy year:2026 · 32025 · 22024 · 62023 · 32022 · 42021 · 12019 · 22017 · 12015 · 224 dated
BillionToOne is a precision diagnostics company that uses molecular counting technology to develop non-invasive prenatal screening and liquid biopsy tests for early disease detection.
BiotechDigital HealthHealthtechMedical DevicesSan Francisco, US
Oguzhan Atay, PhD(Co-Founder, CEO, and Board Chair)inDavid Tsao, PhD(Co-Founder, CTO, and Board Member)inOguzhan Atay(Founder)inDavid Tsao(Founder/CTO)inSukrit Silas(Cofounder)in
Co-investors500 Emerging Europe500 GlobalAsymmetry Venturese2vcFifty YearsFriale+22 more
Omada Health provides virtual-first, integrated care programs for chronic disease management, delivered as data-driven solutions for employers, health plans, and healthcare organizations.
Digital HealthHealthtechWellness & FitnessSan Francisco, US
Andrew DiMichelle(Executive Officer, Director)Adrian James(Executive Officer, Director)inSean Duffy(Executive Officer, Director)inWei-Li Shao(President)inSteve Cook(Chief Financial Officer)in
BoardJonathan Root(Director)in
Co-investorsaMoonAndreessen HorowitzBlackbird GiantsCanvas VenturesDesigner FundFounder Collective+14 more
Oxford Cancer Analytics develops a diagnostics platform that combines reproducible proteomic measurement with AI to produce evidence-based insights supporting clinical decision-making.
AI & Machine LearningBiotechMedical DevicesOxford, GB
Andreas Halner(Founder and Head of Healthcare AI)inHeinrich Roder(Chief Technology Officer)inDaniel Szulc(Chief Product Officer)in
Co-investorsEka VenturesCross-Border Impact VenturesMeridian Health VenturesUK Innovation & Science Seed FundDigitalDx VenturesOnstage+1 more
10x provides an AI-powered back-office service that automates dental practice operations including hygiene recall outreach, treatment follow-up coordination, and missed-call answering.
AI & Machine LearningHealthtechSaaSSan Francisco, US
Max Bohun(Founder)inAman Garg(Founder)in
Co-investorsY CombinatorHassan Lantry (Blast)Initialized CapitalZ Venture Capital
10x Science provides an AI platform that automates protein characterization for drug developers, reducing months of manual analysis to speed the evaluation of therapeutic candidates in early-stage development.
AI & Machine LearningBiotechEnterprise SoftwareSaaSSan Francisco, US
David Roberts(Founder and CEO)inAndrew Reiter(Founder and COO)inVishnu Tejus(Founder and CTO)in
Co-investorsInitialized CapitalY Combinator
23andMe operates a research platform that collects genetic data from millions of users to advance genomic research and health discovery.
BiotechDigital HealthDirect to ConsumerHealthtechLongevityMountain View, US
Anne Wojcicki(CEO and Founder)inLinda Avey(Co-founder)Paul Cheung(Co-founder)Andrew Page(Executive Officer, Director)Kathy Hibbs(Executive Officer)in
BoardEsther Dyson(Director)in
Co-investorsAdam NashAllied Venture PartnersEQUIAMFirebolt Ventures Management Company, LlcG SquaredGV (Google Ventures)+17 more
Adyn uses large inclusive datasets and machine learning to advance personalized medicine for historically under-researched health conditions, with initial focus on reproductive disorders.
AI & Machine LearningDigital HealthHealthtechMedical DevicesWellness & FitnessSeattle, US
Elizabeth Ruzzo(Founder, CEO)inElizabeth Ruzzo, PhD(Founder)in
Co-investorsAscend Venture CapitalDuke Capital PartnersLux CapitalPioneerWestbound Equity PartnersY Combinator+4 more
Aikium combines deep learning with large-scale wet-lab experimentation to design and screen protein libraries, aiming to develop protein therapeutics for hard-to-treat targets such as GPCRs and ion channels.
AI & Machine LearningBiotechDeep Tech
Eswar I(Founder)Venkatesh Mysore(Founder)inDr. Eswar Iyer(CEO | Head of Synthetic Biology)Michael Tolentino(Chief Development Officer)inDr. Shankar Shastry(Vice President | Head of Protein Sciences)
Co-investorsAligned Health VenturesBantam GroupFellows
Alveo Technologies makes a palm-sized molecular diagnostic analyzer with preloaded test cartridges that deliver on-site pathogen results in under an hour, with results sent to a smartphone.
AgTechBiotechMedical DevicesAlameda, US
Ron Chiarello(Executive Officer, Director)inMichael Aicher(Executive Officer, Director)Shaun Holt(Chairman of the Board & Chief Executive Officer)Erik Tyrrell-Knott(President & Chief Business Officer)inScott(Chief Commercial Officer)Slava Elagin(Executive (R&D/Operations))in
Co-investorsBlack Diamond VenturesCelesta CapitalPartners ResoluteSUPPLY CHANGE CAPITAL
Ample builds a modular battery-swapping technology that delivers a full charge to any electric vehicle in under five minutes using lego-like swappable battery modules, without requiring carmakers to redesign their cars.
CleantechEnergyHardwareMobility & Transportation
Co-investorsHemi Ventures, LlcJazzya InvestmentsNew Ground VenturesPrefix CapitalStart CapitalTransform Capital Management+6 more
Antheia uses a yeast-based biosynthesis and fermentation platform to manufacture Key Starting Materials (KSMs) and Active Pharmaceutical Ingredients (APIs) for essential medicines, offering an alternative to fragile agricultural sourcing.
Advanced ManufacturingBiotechHealthtechMenlo Park, US
Christina D. Smolke(Executive Officer, Director)inChristina Smolke(Co-Founder & CEO)inKristy Hawkins(Co-Founder & CSO)inEric d'Esparbes(Chief Financial Officer)inZack McGahey(Chief Operating Officer)inHeidi Pucel(Chief People Officer)in
Co-investorsAmerica's Frontier FundGlobal Health Investment CorporationLam CapitalSherpalo Ventures
Aperiam Bio uses computer-vision algorithms to identify "hyperfolding" protein variants with improved expression, solubility, and stability, aiming for order-of-magnitude gains in protein performance.
AI & Machine LearningBiotechDeep TechAustin, US
Austin Cole(CEO & Founder)Guillaume Cottarel(Head of Program)inRussell Durrett(Chief Business Officer)
Co-investorsOMX VenturesAxial VCKdT Ventures
Aspect Biosystems develops bioprinted tissue therapeutics using a platform that combines AI-powered bioprinting, computational design tools, therapeutic cells, and biomaterials to create implantable allogeneic tissues.
AI & Machine LearningBiotechLongevity
Tamer Mohamed(Founder & CEO)inSam Wadsworth(Co-founder & Chief Scientific Officer)inSimon Beyer(Co-founder & Chief Technology Officer)inLeela Paris(Chief Technical Operations Officer)inMike Scott(Chief Development Officer)inRay Smith(Chief Financial Officer)in
Co-investorsAngel ForumInBC Investment Corp.JDRF T1D FundPage One VenturesPallasite VenturesPangaea Ventures Us Inc.+6 more
Axonis Therapeutics is a biotechnology company developing small-molecule medicines that target KCC2, a mediator of inhibition in the brain, to treat neurological disorders such as epilepsy and pain.
BiotechDeep TechBoston, US
Shane V. Hegarty(Chief Scientific Officer & Co-Founder)inJoanna Stanicka(Chief Executive Officer, President & Co-Founder)inJeff Imbaro(Chief Operating Officer)inTiasha Shafiq(Chief of Staff)in
BoardCorey . Goodman(Director)inJonathan Leff(Director)in
Co-investorsSofinnova VenturesvenBio PartnersMRL Ventures FundCreative Destruction Lab (CDL)Hatteras Venture PartnersIaso Ventures+8 more
Babyscripts provides a maternity care platform with remote patient monitoring, risk screening, and care management services for pregnant and postpartum patients.
Digital HealthFemTechHealthtechSaaS
Juan Pablo Segura(Founder)inAnish Sebastian(Founder & CEO)in
Co-investorsCU Healthcare Innovation FundMemorialCare Innovation FundPhilips VenturesAAF Management Ltd.Builders + BackersIrishAngels+5 more
Biosynthetic Technologies develops innovative solutions in R&D and operations for sustainability-focused applications.
Advanced ManufacturingBiotechCircular EconomyCleantechNew MaterialsIrvine, US
Allen Barbieri(Executive Officer, Director)inDr. Matt Kriech(CEO)
BoardBernhard Mohr(Director)Meghan Sharp(Director)Kent Wasson(Director)Steve Bierschenk(Director)
Co-investorsHG VenturesAthosGlobal Health Investment CorporationIn-Q-TelSherpalo VenturesViking Global Investors
Biomemory develops DNA-based data storage systems for data centers, offering an alternative storage tier optimized for long-term archival, density, and energy efficiency.
Climate TechData & InfrastructureDeep Tech
Hyunjun Park(CEO)
Co-investorsFifty YearsHemisphere Ventures LLCNew Enterprise Associates (NEA)Prefix CapitalZ Venture CapitalCantos Ventures+3 more
CatenaBio develops precision conjugation technology using native amino acids to enable biotherapeutic fusions of small molecules, nucleic acids, enzymes, and cells.
BiotechDeep TechHealthtechMedical DevicesBerkeley, US
Marco Lobba(Founder)inMatthew Francis(Founder)inMarco Lobba, Ph.D.(Founder)in
Co-investorsCALIFORNIA INNOVATIONCreative Destruction Lab (CDL)FREEFLOWIaso VenturesJude GomilaLongeVC+14 more
Convergent Genomics is a genomic diagnostics company that uses next-generation sequencing and liquid biopsy to extract DNA from urine and detect, monitor, and predict urothelial (bladder) cancer non-invasively.
AI & Machine LearningBiotechDigital Health
Trevor Levin(Founder, President & Chief Scientific Officer)inBrian Slingerland(Chief Executive Officer)inBrian Mazzarella(Chief Medical Officer)Iden Haddadzadeh(Chief Operating Officer)
Curai Health offers virtual primary care through a chat-based service, connecting patients with a care team of medical experts for diagnosis, treatment, prescription renewals, and management of conditions such as flu, hypertension, and diabetes.
AI & Machine LearningConsumerDigital HealthHealthtech
Neal Khosla(Cofounder)in
Co-investorsKhosla VenturesPerot JainWestRiver Group
Curve Pay is a digital wallet that combines multiple bank cards into one, letting users switch which card paid for a purchase after the fact, avoid foreign exchange fees, and earn cashback on top of existing card rewards.
ConsumerFintech
Shachar Bialick(Founder & CEO)in
Co-investorsCathay InnovationCohen CircleFuel Venture CapitalHanaco Venture CapitalLifeX VenturesMouro Capital+11 more
Curve Bio builds Whole-Body Intelligence models from its Whole-Body Atlas, a molecular map of the body, to power blood tests that monitor organ health in chronic disease patients.
AI & Machine LearningBiotechDigital HealthDallas, US
Nathan Hunkapiller(Founder)inProf. Shan Wang, PhD(Chief Innovation Officer and Scientific Founder)Ritish Patnaik, PhD(Chief Executive Officer)CHUBA OYOLU(Executive Officer)SHAN XIANG WANG(Executive Officer, Director)RITISH PATNAIK(Executive Officer, Director)
Co-investorsFirst Spark Ventures, LlcLifeX VenturesLuma GroupNZVCMintaka
Delineate builds AI agents that help pharmaceutical companies design clinical trials more quickly by converting existing trial research into specialized datasets, reducing the time scientists spend on trial preparation.
AI & Machine LearningBiotechDeveloper ToolsEnterprise SoftwareSaaSBoston, US
Emily Nieves(Founder)inJawad Iqbal(Founder)in
Co-investorsY CombinatorCannage CapitalCapitoriaPeak XV PartnersUnpopular Ventures
DermBiont develops SM-030, a topical drug candidate targeting melasma, a skin pigmentation disorder, by inhibiting PKC-beta to address the underlying cause of hyperpigmentation.
BiotechDigital HealthMedical DevicesBoston, US
Robert Brucker(Executive Officer)inKarl R. Beutner(Executive Officer, Director)inNichola Eliovits(Executive Officer, Director)inMax Dawson(Executive Officer)in
BoardWilder Ramsey(Director)inJennifer Lee(Director)
Co-investorsJoyance PartnersOlive Tree CapitalStart CapitalToba CapitalValia VenturesNewpath Partners+1 more
One Health operates a clinical trial platform using canine cancer data to accelerate and de-risk human oncology drug development.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesSan Francisco, US
Christina Lopes(Co-Founder & CEO)inBenjamin Lewis(Co-Founder)inchristina lopes(Founder)in
Co-investorsAndreessen HorowitzaVentureGlobal BrainIKJ CapitalMaC Venture CapitalMyAsiaVC+13 more
Fluent Bio develops software for analyzing single-cell RNA sequencing data, producing count matrices and diagnostic outputs for researchers using Illumina sequencing libraries.
BiotechDeveloper Tools
Co-investorsCota CapitalIllumina VenturesSamsara BioCapital
Foresight Diagnostics develops ultra-sensitive molecular diagnostic tests that combine genomics and bioinformatics to detect minimal residual disease and circulating tumor DNA across multiple cancer types.
BiotechDigital HealthHealthtechBoulder, US
Co-investorsAgent CapitalBoulder VenturesCU Healthcare Innovation FundForesite CapitalPear VC
Glyphic Biotechnologies develops ProSE™, a high-throughput de novo protein sequencing technology for analyzing proteomes with single-molecule sensitivity.
BiotechDeep TechBerkeley, US
Daniel Estandian(Founder)inEd Boyden(Founder)Josh Yang(Founder)in
BoardCraig Asher(Director)inJimmy Yun(Director)in
Co-investorsArtis VenturesBlack FlagFoundersX VenturesHarpoon VenturesLongeVCModi Ventures+7 more
Iantrek develops micro-interventional ophthalmic surgical technologies focused on enhancing total outflow through the uveoscleral pathway to treat glaucoma.
BiotechHealthtechMedical DevicesElkins Park, US
Tsontcho Ianchulev(Executive Officer, Director)Sean Ianchulev(Founder & Chairman of the Board (CMO))inMichael Haydin(Executive Officer)
BoardJeffry K Weinhuff(Director)Farrell Tyson(Director)Stephen Bloch(Director)in
Co-investorsaMoonVisionary VenturesCanaan PartnersFemHealth VenturesJSD Capital, LLCUS Venture Partners
J.P.
Enterprise SoftwareFintechNew York City, US
Co-investors8VCBelief CapitalLux CapitalSilent VenturesSV AngelY Combinator
Infinimmune discovers and develops antibody therapeutics using proprietary sequencing technology and AI-powered optimization.
AI & Machine LearningBiotechMedical Devices
Lance Hepler(Founder)inKatie Pfeiffer(Founder)inMichael Gibbons(Founder)inWyatt McDonnell(Founder)indavid jaffe(Founder)in
Co-investorsPear VCPlayground GlobalRA CapitalAxial VCPaladin Capital GroupTrammell Venture Partners (TVP)
Insamo develops an automated platform for drug discovery that designs, synthesizes, and tests cyclic peptides at scale using machine learning and proprietary experimental data.
AI & Machine LearningBiotechDeep TechChippendale, AU
Tim Craven(CEO)inToby Passioura(CSO)inGlen McIntyre(COO)
BoardCOREY GOODMAN(Director)inMATT HERSHENSON(Director)in
Co-investorsBEVCMRL Ventures FundPlayground GlobalvenBio PartnersAxial VCvenBio Global Strategic
Integrated Biosciences is a biotech company developing small molecule therapeutics for age-related diseases, using optogenetics, chemistry, and AI to study aging biology.
AI & Machine LearningBiotechLongevityRedwood City, US
Felix Wong(Executive Officer, Director)inDaniel J. Anderson(Chief Scientific Officer)inThemasap Khan(Director)
BoardKeith Loebner(Director)
Co-investorsSutter Hill VenturesIllumina VenturesOverlap Holdings
Invitae provides genetic testing services to patients and clinicians across the United States, offering broad test offerings and genetic counseling to inform health decisions at every stage of life.
BiotechDigital HealthHealthtechMedical DevicesSan Francisco, US
Sean George(Executive Officer, Director)inRandal Scott(Executive Officer, Director)Shelly Guyer(Executive Officer)inLee Bendekgey(Executive Officer)inGeoffrey Crouse(Director)
BoardEric Aguiar(Director)in
Co-investorsDecheng CapitalFifty YearsManta Ray VenturesOberland CapitalPrefix CapitalTech Wildcatters+3 more
JustPaid is a B2B billing automation platform that uses AI to create, send, and track invoices, run collections, and reconcile payments across tools like Stripe, QuickBooks, Xero, and Salesforce.
AI & Machine LearningFintechSaaS
Co-investorsThe Lab Private Equity Fund 2, LPTRAC (Third Round Analytics Capital)Dating Group
Kernal Bio is a synthetic biology company developing selective mRNA drugs to treat serious illnesses, with a focus on cancer therapeutics and improving patient outcomes.
AI & Machine LearningBiotechHealthtechMedical DevicesBoston, US
Yusuf Erkul(Founder)inJeff Ozdemir(Founder)inBurak Yilmaz(Founder)inBurak YILMAZ(Founder)inCatherine Moroski(Executive Officer, Director)inOguzhan Yilmas(Director)
Co-investorsAsymmetry VenturesFoundersX VenturesHOF CapitalHummingbird VenturesSAV (Scale Asia Ventures)UNCOMMON DENOMINATOR+13 more
Lemonaid Health is a telehealth company that lets patients access medical care and treatment online from home, including services like contraceptive pill prescriptions and UTI treatment.
ConsumerDigital HealthDirect to ConsumerHealthtechSan Francisco, US
Paul Johnson(Founder)in
Co-investorsArtis VenturesCorrelation VenturesDaybreak PartnerseGateway CapitalFirebolt Ventures Management Company, LlcHealth Velocity Capital+6 more
Loopfour provides finance automation software that enables organizations to automate workflows such as invoicing, contracts, payments, and reconciliations while maintaining control through triggers, integrations, and approval mechanisms.
AI & Machine LearningEnterprise SoftwareFintechSaaSSan Francisco, US
Daniel Kivatinos(Founder/CEO)inAnelya Grant(Founder)inVinay Datta Pinnaka(Founder)in
Co-investorsY CombinatorAidenlair CapitalAndreessen HorowitzDavidovs Venture CollectiveDecacorn CapitalGaingels+12 more
Manus Bio uses industrial biotechnology and engineered microbial cell factories to produce "BioAlternatives" — sustainable versions of molecules normally sourced from petrochemicals, agriculture, or animal husbandry — and offers a scale-up platform covering cell factory design through biomanufacturing.
BiotechFoodTechNew MaterialsAugusta, US
Ajikumar Parayil(Executive Officer, Director)inAji Parayil(Co-founder)inGreg Stephanopoulos(Co-founder)
BoardJason Whaley(Director)inCarsten Boers(Director)inRichard Goldstein(Director)
Co-investors+ND CapitalAlumni VenturesEnergy Impact PartnersLiebenthal VenturesNelstone VenturesNXT Ventures+4 more
Nanite develops resorbable polymer nanoparticles (PNPs) for virus-free genetic drug delivery, using high-throughput synthesis and AI to design precision delivery vectors for gene therapy.
AI & Machine LearningBiotechDeep TechBoston, US
Shashi Murthy(Executive Officer)inSean Kevlahan(Co-founder & CEO)inThomas Neenan(Co-founder & CBO)in
Co-investorsBantam Group
Outpace Bio develops engineered protein technologies and cell therapies to treat solid tumors, focusing on protein design and T cell engineering to improve cancer treatment efficacy and safety.
BiotechDeep TechMedical DevicesSeattle, US
Marc Lajoie(Co-founder & Chief Executive Officer)inScott Boyken(Co-founder & Chief Innovation Officer)inStanley Riddell(Co-Founder and Scientific Advisor)Aaron Foster(Executive Officer)inCharity Scripture(Executive Officer)inEric Soller(Executive Officer)in
Co-investorsArtis VenturesRA CapitalAbstract VenturesATEL VenturesAtinum Investment Co. Ltd.Modi Ventures+8 more
Overt Bio develops cell therapies that link genes to immune functions using genome-scale discovery platforms.
AI & Machine LearningBiotechMedical DevicesNew York, US
Dr. Legut(Co-Founder and CEO)Dr. Sanjana(Co-Founder)Mateusz Legut(Executive Officer, Director)Neville Sanjana(Director)Mat Legut(Founder)in
BoardVasudev Bailey(Director)in
Co-investorsArtis VenturesFusionHAWKTAILWingAlexandriaGaingels+1 more
This page is a distribution, marketing, and reseller partner directory for PRWeb, an online press release distribution service.
Marketing TechMedia & EntertainmentSaaS
Co-investorsAdvance Venture PartnersAngel Physicians FundAvestria VenturesAviv Venture CapitalBIGR VenturesBlue Venture Funds+15 more
Ermit designs and manufactures connected hardware devices with embedded software and AI capabilities, serving companies building IoT and field-operated products.
CybersecurityHardwareIoTNew York, IT
Emanuele Musini(CEO and Director)James Wyman(CFO and Director)
BoardYogendra Jain(Director)
Co-investorsBioAdvanceHackensack Meridian Health Bear's DenHikma VenturesSamsung VenturesStanley Ventures
Prellis Biologics runs an antibody discovery platform that uses two-photon laser-bioprinted human immune organoids combined with machine learning to identify fully human antibody therapeutics.
AI & Machine LearningBiotechDeep TechHayward, US
Melanie Matheu(Executive Officer, Director)Noelle Mullin(Executive Officer, Director)in
BoardArvind Gupta(Director)Rohit Sharma(Director)in
Co-investorsBlack Diamond VenturesCelesta CapitalOpen Field CapitalPrefix CapitalCantos VenturesKhosla Ventures+3 more
QUiCKR develops rapid genetic modification quantification kits for cell and gene therapy R&D programs, analyzing structural variants, edits, and genome integrity to accelerate development timelines and reduce costs.
BiotechDeep TechMedical Devices
Charles Blanluet(Founder)in
Co-investorsHCVCLexi Ventures
Range Bio (Range Biotechnologies) develops next-generation diagnostics using translational proteomics for applications in human health.
BiotechHealthtechMedical Devices
Brandon Wilson, Ph.D.(Co-founder & CEO)Brandon Wilson(Co-founder & CEO)in
Co-investorsArtis VenturesFifty YearsHAWKTAILPage One VenturesPear VCPillar VC
Gene editing company, with Civilization as founding investor, acquired by Intellia for $200M.
Co-investorsPrefix Capital
Rocket Pharmaceuticals develops gene therapies to treat patients with rare genetic diseases, focusing on cardiovascular and hematologic disorders.
BiotechDigital HealthMedical Devices
Gaurav Shah(Co-founder & Chief Executive Officer)in
BoardRoderick Wong(Director)inNaveen Yalamanchi(Director)in
Co-investorsAvoro Capital AdvisorsBroadview VenturesFrazier Life SciencesLifeSci Venture PartnersRTW Investments L.P.
R-Zero provides AI software that reduces HVAC energy consumption in buildings by 20-40% using real-time occupancy and air quality data, with no infrastructure changes required.
CleantechEnterprise SoftwareIoT
Co-investorsDBL PartnersLeadout CapitalQualcomm VenturesUpfront Ventures
Sensible Biotechnologies develops a cell-based mRNA design and manufacturing platform that produces pure, low immunogenicity mRNA therapeutics for drug development.
AI & Machine LearningBiotechDeep TechHealthtechOxford, GB
Miroslav Gasparek(Founder)inMarian Kupculak(Founder)in
BoardVishal Gulati(Director)Joel Schoppig(Director)
Co-investorsKAYARecode VenturesTraun VenturesY CombinatorZAKA VCAmino Collective+11 more
Shield Bio develops nanopore sequencing technology for clinical use, designed to run rapid genetic tests in healthcare settings.
HealthtechMedical DevicesSan Francisco, US
Fred Turner(Founder/CEO)in
Co-investorsY CombinatorAndreessen HorowitzEsas VenturesFrialeIntuition CapitalKnollwood Investment Advisory+6 more
Siren Biotechnology develops next-generation AAV (adeno-associated virus) platforms for gene therapy applications, including gene repair, gene transfer, and gene editing.
BiotechDigital HealthMedical DevicesSan Francisco, US
Dr. Nicole Paulk(CEO, Founder, and President)inLauren Kelly(Founder)inSharon Tetlow(Director)Brad Allen(Director)
Co-investorsArtis VenturesAvilaCarnrite VenturesHAWKTAILNZVCPlum Alley Investments+3 more
Tahoe Bio AI applies machine learning and computational biology to drug discovery and development.
AI & Machine LearningBiotechDeep TechSouth San Francisco, US
Nima Alidoust(CEO & Cofounder)inJohnny Yu(CSO & Cofounder)inHani Goodarzi(Cofounder)inKevan Shokat(Cofounder)
Co-investorsAIX VenturesAmplify PartnersWingDatabricks Ventures
Teiko provides CLIA-validated high-dimensional cytometry services—including spectral flow and mass cytometry panels, blood preservation kits, gating, and a data analysis dashboard—for immune cell profiling in clinical trials.
BiotechDigital HealthHealthtechSalt Lake City, US
Ramji Srinivasan(Executive Officer, Director)inMatt(Co-founder)inMatthew Spitzer(Director)
BoardVictor Wang(Director)in
Co-investorsHAWKTAILHOF CapitalTau VenturesTwine VenturesWestern Technology InvestmentEPIC VENTURES+1 more
TenSixty uses machine learning and cell biology expertise to identify novel antibody targets on cancer cells for the development of new cancer therapeutics.
AI & Machine LearningBiotechMedical DevicesCambridge, US
Daniel Montoro(Executive Officer, Director)inKarthik Jagadeesh(Executive Officer, Director)Christoph Muus(Director)
BoardDipchand Nishar(Director)Sara Choi(Director)in
Co-investorsGeneral CatalystWing
Tigatx develops engineered IgA antibodies designed to engage neutrophils as a cancer treatment approach.
Biotech
Co-investorsBioGeneration Ventures
uLab Systems builds digital orthodontics tools, including software (uDesign, uAssist) and uSmile clear aligners manufactured in the USA, for dental professionals and orthodontic practices.
BiotechDigital HealthHealthtechMedical DevicesSaaSMemphis, US
AmirAli Talasaz(Director)Mark Foley(Director)David Thrower(Executive Officer)Tim Dumore(Director)Rita O'Connor(Director)Robert Doty(Executive Officer)
Co-investors7 Gate VenturesAPERTURE Venture PartnersTachles VC
Verbal is an AI platform that audits healthcare interactions—including calls, video telemedicine, clinical notes, and chat—to ensure compliance with internal protocols and external standards like TJC and URAC.
AI & Machine LearningDigital HealthHealthtechSaaSCovina, US
Eric Lee Escobedo WuWaleed Mohsen
Co-investors500 GlobalAUTHENTIC VENTURESChicago Early Growth Ventures (CEGV)Cosmic Venture PartnersEast Post Road VenturesK20 Fund+2 more
Wild Earth manufactures plant-based dog food formulated to meet nutritional standards while reducing environmental impact compared to traditional meat-based pet food.
Circular EconomyConsumerFoodTechHealthtech
Ryan Bethencourt(Founder)inRon Shigeta(Founder)inAbril Estrada(Founder)Kristin Wuhrman(Founder)
Co-investorsAt One VenturesBabel VenturesBig Idea VenturesBlue Horizon CorporationEvolution VC PartnersMaC Venture Capital+4 more
Wyndly provides personalized allergy treatment through board-certified doctors, delivering clinical immunotherapy and testing directly to patients' homes without requiring office visits.
Digital HealthHealthtechWellness & FitnessNew York City, US
Aakash Shah(Founder, CEO)inManan Shah(Founder, Chief Medical Officer)in
Co-investorsImmeasurableY CombinatorBeagle VenturesGoodwater CapitalSide Door VenturesUnderdog Labs
xCures builds an AI platform that assembles and structures fragmented medical records into organized, decision-ready clinical data for healthcare organizations.
AI & Machine LearningData & InfrastructureDigital HealthHealthtechOakland, US
Mika Newton(Chief Executive Officer)inGlenn Kramer(Chief Technology Officer)inKenny Wong(Chief Product Officer)in
Co-investorsHarmonix FundHarvard Business School Alumni Angels of Greater New YorkHealthtech CapitalInnovius CapitalLauder PartnersMetaplanet+6 more
YourChoice Therapeutics is developing YCT-529, a non-hormonal oral contraceptive for men currently in Phase 2 clinical trials.
BiotechFemTechHealthtech
Akash Bakshi, MSc(Co-founder & CEO)Nadja Mannowetz, PhD(Co-founder & CSO)
Co-investorsBlue Bear VenturesForeground CapitalFuture VenturesNorth South VenturesPortfoliaOlive Tree Capital+1 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
EvonetixExcision BioKlivoRewriteSingular BioVC
Exits · 10
2 IPOs · 8 acquisitions · showing 8BillionToOneNASDAQ: BLLNOmada HealthNASDAQ: OMDAForesight Diagnosticsacq. by NateraLemonaidacq. by 23andmePentec Health Celebrates 35th Anniversaryacq. by Wellspring Capital ManagementRewriteacq. by IntelliaRewrite Therapeuticsacq. by IntelliaSingular Bioacq. by Invitae
Portfolio news
latest coverage across their companies23andme · en.wikipedia.org · Sep 22, 2026
xCures · thesaasnews.com · Jun 25, 2026
10x · ycombinator.com · Apr 29, 2026
10x Science · finsmes.com · Apr 22, 2026
Frequently asked questions
- How many investments has Civilization Ventures Management, Llc made?
- Civilization Ventures Management, Llc has 70 tracked investments, 10 of which have exited, including 6 dated in the last 24 months.
- What stage does Civilization Ventures Management, Llc invest at?
- Civilization Ventures Management, Llc invests at the Pre-Seed, Seed, Growth stages.
- What is Civilization Ventures Management, Llc's typical check size?
- Civilization Ventures Management, Llc typically writes checks of $1M – $10M.
- What sectors does Civilization Ventures Management, Llc focus on?
- Civilization Ventures Management, Llc focuses on AI & Machine Learning, Biotech, Digital Health, Healthtech, Longevity, Medical Devices.
- Where is Civilization Ventures Management, Llc located?
- Civilization Ventures Management, Llc is headquartered in Tiburon, US.
- Does Civilization Ventures Management, Llc lead rounds?
- Yes, Civilization Ventures Management, Llc leads investment rounds.
- Who does Civilization Ventures Management, Llc co-invest with?
- Civilization Ventures Management, Llc most often shares deals with Y Combinator, Prefix Capital, Artis Ventures, among 258 tracked co-investors.
Images
Co-investors · 3
Foresite Capital is a healthcare-focused investment firm backing companies at the intersection of technology and biotechnology to personalize healthcare and accelerate medical innovation.
Lookout Ventures is a seed-stage venture capital firm backing B2B SaaS startups located outside the major coastal tech hubs across the United States.
Antler is a global early-stage venture capital firm that backs founders from company inception through to IPO, operating across roughly 30 locations worldwide and running cohort-based programs to help entrepreneurs build and scale companies.
Firms observed investing alongside Civilization Ventures Management, Llc, from public investor directories. Shared companies are the overlap with Civilization Ventures Management, Llc's recorded portfolio.
Similar investors
Khosla Ventures is a venture capital firm that backs bold, early-stage, technology-driven companies across deep tech and other sectors, providing hands-on 'venture assistance' to help founders build category-defining businesses.
OrbiMed is a healthcare-focused investment firm providing tailored financing solutions and global resources to build world-class healthcare companies across biopharmaceuticals, medical devices, digital health, diagnostics, and healthcare services.
Foresite Capital is a healthcare-focused investment firm backing companies at the intersection of technology and biotechnology to personalize healthcare and accelerate medical innovation.
A globally recognized venture capital firm designed to provide access to highly competitive venture deals to individual investors, consistently recognized for top-decile DPI performance and as one of the most active US venture firms.
Alumni Ventures (AV) is a venture capital firm that co-invests alongside lead VCs in startups, backing founders with capital and access to a large investor and operator community.



















.jpeg)






































































































































































































__Twitter.png)









































































.png)




























